4lh5

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (16:19, 20 September 2023) (edit) (undo)
 
Line 4: Line 4:
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[4lh5]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LH5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4LH5 FirstGlance]. <br>
<table><tr><td colspan='2'>[[4lh5]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LH5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4LH5 FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CAS:S-(DIMETHYLARSENIC)CYSTEINE'>CAS</scene>, <scene name='pdbligand=LF0:(2S)-TERT-BUTOXY[4-(3,4-DIHYDRO-2H-CHROMEN-6-YL)-2-METHYLQUINOLIN-3-YL]ETHANOIC+ACID'>LF0</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.19&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CAS:S-(DIMETHYLARSENIC)CYSTEINE'>CAS</scene>, <scene name='pdbligand=LF0:(2S)-TERT-BUTOXY[4-(3,4-DIHYDRO-2H-CHROMEN-6-YL)-2-METHYLQUINOLIN-3-YL]ETHANOIC+ACID'>LF0</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4lh5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4lh5 OCA], [https://pdbe.org/4lh5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4lh5 RCSB], [https://www.ebi.ac.uk/pdbsum/4lh5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4lh5 ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4lh5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4lh5 OCA], [https://pdbe.org/4lh5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4lh5 RCSB], [https://www.ebi.ac.uk/pdbsum/4lh5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4lh5 ProSAT]</span></td></tr>
</table>
</table>

Current revision

Dual inhibition of HIV-1 replication by Integrase-LEDGF allosteric inhibitors is predominant at post-integration stage during virus production rather than at integration

PDB ID 4lh5

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools